Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...
Please provide your email address to receive an email when new articles are posted on . Surveillance led to detection of smaller tumors among patients at high risk for pancreatic cancer. Individuals ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Please provide your email address to receive an email when new articles are posted on . Over 80% of people at high risk for lung cancer were unaware of screening or had not discussed it with a doctor.
Here are 12 recent statistics on colorectal cancer screening rates. 68.9 colonoscopies per 1 million patients: The decrease in colorectal cancer screening rates per month for insured patients during ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it has provided genomic newborn screenings (gNBS) for ...
A data breach at DISA Global Solutions, Inc., a third-party employment screening services provider, affected more than 3.3 million people, the company said. The company, which provides drug and ...
Consumer advocates have sued RentGrow, a tenant screening company used by landlords that provide low-income housing in D.C. and other cities, for failing to ensure that its background checks are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results